Поиск
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.

СПИСОК ЛИТЕРАТУРЫ

1. Gurtovoi B.L.., Emelianova, A.I., Voropayeva S.D.. Puerperal mastitis. Research and practice results for diagnosis and treatment. // Obstet. Gynaecol. 2008. № 5. P. 15–18. 2. Salamon C.W. et al. [Seven years of experience at a specialized breast feeding clinic. Incorrect breast feeding technique and milk stasis are the most common problems]. // Lakartidningen. 2000. Vol. 97, № 43. P. 4838–4842. 3. Kiosov A.F. Lactostasis and mastitis: what can a neonatologist and a pediatrician do? // Vopr. Prakt. Pediatr. 2020. Vol. 15, № 2. P. 99–106. 4. Iskakov, S.S.; Malgazhdarova, B.S.; Tulemisova, A.A.; Shegenov G.A. Clinical protocol for diagnosis and treatment. Lactational mastitis and lactostasis. Republican Center for Healthcare Development of the Ministry of Health of the Republic of Kazakhstan. 2019. 15 p. 5. Amir L.H. ABM Clinical Protocol #4: Mastitis, Revised March 2014 // Breastfeed. Med. 2014. Vol. 9, № 5. P. 239–243. 6. World Health Organization. Guideline: Protecting, Promoting and Supporting Breastfeeding in Facilities Providing Maternity and Newborn Services. 2017. 120 p. 7. Pustonina O.A. Lactation Mastitis and Milk Stasis: Controversy Over Tactics // Gynecol. Endocrinol. 2014. № 8 (96). P. 64–67. 8. Zakharova I.N. et al. Mastitis and/or plugged ducts? How to differentiate, help and treat? // Med. Counc. 2019. № 11. P. 10–15. 9. Pustotina O.A. SUMMING UP THE EXPERIENCE GAINED IN THE TREATMENT OF PUERPERAL MASTITIS IN 642 PATIENTS IN RUSSIA. COMPARATIVE ANALYSIS WITH INTERNATIONAL RECOMMENDATIONS // Arkhiv Akusherstva i Ginekol. im. V.F. Snegiryova. 2015. № 2 (2). P. 42–47. 10. Pustotina O.A. Lactational mastitis and lactostasis: tactical contraversions // Woman’s Heal. 2013. № 10 (86). P. 74–78. 11. Pustotina O.A. BREASTFEEDING – PROBLEMS AND SOLUTIONS // Ulyanovsk Med. Biol. J. 2011. № 4. P. 131–139. 12. Яковлев Я., Манеров Ф. Лактостаз И Лактационный Мастит В Практике Педиатра // Сибирское Медицинское Обозрение. 2015. № 2 (92). P. 32–41. 13. Balushkina A.A. et al. New trends in prevention and treatment of postpartum mastitis and lactostasis // Med. Counc. 2019. № 12. P. 136–141. 14. Alekseev. S. A.; et al. ACUTE PURULENT LACTATION MASTITIS AND 32 PECULIARITIES. 2018. P. 93–98. 15. Stafford I. et al. Community-Acquired Methicillin-Resistant Staphylococcus aureus Among Patients With Puerperal Mastitis Requiring Hospitalization // Obstet. Gynecol. 2008. Vol. 112, № 3. P. 533–537. 16. ACOG Committee Opinion No. 361: Breastfeeding: Maternal and Infant Aspects // Obstet. Gynecol. 2007. Vol. 109, № 2, Part 1. P. 479. 17. Karacam Z., Saglik M. Breastfeeding problems and interventions performed on problems: systematic review based on studies made in Turkey // Türk Pediatr. Arşivi. 2018. Vol. 53, № 3. P. 134–148. 18. Seyyedeh Hanieh A, Sedigheh A, Alireza Akbarzadeh B S.E. Effects of Aloe vera gel on breast fissures in breastfeeding women. // Pajoohandeh. 2014. № 19(1). P. 13–17. 19. Пустотина, О.А., Павлютенкова Ю.А. Лактационный мастит и лактостаз. // Российский вестник акушера-гинеколога. 2007. № 2. P. 55–57. 20. Левицкая, С.К. Е.Г.Ф. Некоторые аспекты внутриутробного инфицирования новорожденных. // Акушерство и гинекология. 2004. № 11. P. 5–7. 21. Гостищев В.К. Инфекции в хирургии. Москва: ГЭОТАР-Медиа, 2007. 768 p. 22. HSIEH C.-H. et al. Factors Influencing Postpartum Fatigue in Vaginal-Birth Women: Testing a Path Model // J. Nurs. Res. 2018. Vol. 26, № 5. P. 332–339. 23. Boushra M., Rathbun K.M. Postpartum Headache // StatPearls. 2021. 24. Leung S.S. Breast pain in lactating mothers. // Hong Kong Med. J. = Xianggang yi xue za zhi. 2016. Vol. 22, № 4. P. 341–346. 25. Malevic A., Jatuzis D., Paliulyte V. Epidural Analgesia and Back Pain after Labor. // Medicina (Kaunas). 2019. Vol. 55, № 7. 26. Pereira T.R.C., Souza F.G. De, Beleza A.C.S. Implications of pain in functional activities in immediate postpartum period according to the mode of delivery and parity: an observational study. // Brazilian J. Phys. Ther. Vol. 21, № 1. P. 37–43. 27. Mevorach Zussman N. et al. Protracted postpartum urinary retention-a long-term problem or a transient condition? // Int. Urogynecol. J. 2020. Vol. 31, № 3. P. 513–519. 28. Burgio K. Urinary incontinence in the 12-month postpartum period // Obstet. Gynecol. 2003. Vol. 102, № 6. P. 1291–1298. 29. Turawa E.B., Musekiwa A., Rohwer A.C. Interventions for preventing postpartum constipation. // Cochrane database Syst. Rev. 2015. № 9. P. CD011625. 30. Poskus T. et al. Haemorrhoids and anal fissures during pregnancy and after childbirth: a prospective cohort study. // BJOG. 2014. Vol. 121, № 13. P. 1666–1671. 33 31. Martínez-Galiano J.M. et al. Relationship between parity and the problems that appear in the postpartum period. // Sci. Rep. 2019. Vol. 9, № 1. P. 11763. 32. Park S.-H. et al. [Effect of Kegel exercise to prevent urinary and fecal incontinence in antenatal and postnatal women: systematic review]. // J. Korean Acad. Nurs. 2013. Vol. 43, № 3. P. 420–430. 33. Zhumanova E.N. et al. [Myostimulating effect of comprehensive application of general magnetotherapy, fractional CO2 laser, electro-myostimulation and special complex of exercise in patients with rectoceleal after open-peconstructure]. // Khirurgiia (Sofiia). 2020. № 11. P. 79–85. 34. Srkalović Imširagić A. et al. Prediction of posttraumatic stress disorder symptomatology after childbirth - A Croatian longitudinal study. // Women Birth. 2017. Vol. 30, № 1. P. e17–e23. 35. Senat M. V. et al. Post-partum: recommandations pour la pratique clinique-Texte court // J. Gynecol. Obstet. Biol. la Reprod. Elsevier Masson SAS, 2015. Vol. 44, № 10. P. 1157– 1166. 36. Демьянчук Н.Р.. et al. Особенности цитокинового спектра при лактостазе и лактационном мастите // Лабораторная диагностика Восточная Европа. 2015. № 3–4. P. 142–147. 37. Stuebe A., Auguste T., Gulati M. Recommendations and Conclusions Presidential Task Force on Redefining the Postpartum Visit Committee on Obstetric Practice Optimizing Postpartum Care Committee Opinion Optimizing Postpartum Care e141 // Obstet. Gynecol. 2018. Vol. 131, № 5. P. 140–150. 38. Pavord S. et al. UK guidelines on the management of iron deficiency in pregnancy // Br. J. Haematol. 2020. Vol. 188, № 6. P. 819–830. 39. GHERMAN R.B. et al. Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy // Obstet. Gynecol. 1999. Vol. 94, № 5. P. 730–734. 40. James A.H. et al. Venous thromboembolism during pregnancy and the postpartum period: Incidence, risk factors, and mortality // Am. J. Obstet. Gynecol. 2006. Vol. 194, № 5. P. 1311–1315. 41. O’Herlihy C. Reviewing maternal deaths to make motherhood safer: 2006-2008 // BJOG An Int. J. Obstet. Gynaecol. 2011. Vol. 118, № 11. P. 1403–1404. 42. Simpson E.L. et al. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database // BJOG An Int. J. 34 Obstet. Gynaecol. 2001. Vol. 108, № 1. P. 56–60. 43. Sénat M.-V. et al. Postpartum practice: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF) // Eur. J. Obstet. Gynecol. Reprod. Biol. 2016. Vol. 202. P. 1–8. 44. De Winter J. et al. The value of postpartum ultrasound for the diagnosis of retained products of conception: A systematic review. // Facts, views Vis. ObGyn. 2017. Vol. 9, № 4. P. 207–216. 45. Stavros A.T., Rapp C.L., Parker S.H. Breast ultrasound. eBook / ed. Philadelphia P.: L.W.& W. Philadelphia, Pennsylvania, 2004. 1015 p. 46. Sabate J.M. et al. Radiologic Evaluation of Breast Disorders Related to Pregnancy and Lactation // RadioGraphics. 2007. Vol. 27, № suppl_1. P. S101–S124. 47. Lomova N.A. et al. Hemorrhoids in pregnant and postpartum women: principles of therapy // Med. Counc. 2016. № 2. P. 22–25. 48. Shin G.H., Toto E.L., Schey R. Pregnancy and postpartum bowel changes: constipation and fecal incontinence. // Am. J. Gastroenterol. 2015. Vol. 110, № 4. P. 521–529; quiz 530. 49. Francisco A.A. et al. Ice pack induced perineal analgesia after spontaneous vaginal birth: Randomized controlled trial // Women and Birth. 2018. Vol. 31, № 5. P. e334–e340. 50. East C. et al. Local cooling for relieving pain from perineal trauma sustained during childbirth // Cochrane Database of Systematic Reviews / ed. East C. Chichester, UK: John Wiley & Sons, Ltd, 2007. 51. Pitangui A.C.R. et al. High-frequency TENS in post-episiotomy pain relief in primiparous puerpere: a randomized, controlled trial. // J. Obstet. Gynaecol. Res. 2012. Vol. 38, № 7. P. 980–987. 52. Pitangui A.C.R. et al. Low and high-frequency TENS in post-episiotomy pain relief: a randomized, double-blind clinical trial. // Brazilian J. Phys. Ther. Vol. 18, № 1. P. 72–78. 53. Yip S.-K. et al. Urinary retention in the post-partum period: The relationship between obstetric factors and the post-partum post-void residual bladder volume // Acta Obstet. Gynecol. Scand. 1997. Vol. 76, № 7. P. 667–672. 54. Yip S.-K. et al. Postpartum Urinary Retention // Obstet. Gynecol. 2005. Vol. 106, № 3. P. 602–606. 55. Dolezal P, Ostatnikova M, Balazovjechova B, Psenkova P Z.J. Covert postpartum urinary retention: causes and consequences (PAREZ study) // Int Urogynecol J. 2022. Vol. 33, № 8. P. 2307–2314. 35 56. Victora C.G. et al. Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect // Lancet. 2016. Vol. 387, № 10017. P. 475–490. 57. American Academy of Pediatrics. Fish: What Pregnant Women and Parents Should Know: Draft Updated Advice by FDA and EPA // Diet. Guidel. Am. 2019. P. 1. 58. Lando A.M., Fein S.B., Choinière C.J. Awareness of methylmercury in fish and fish consumption among pregnant and postpartum women and women of childbearing age in the United States // Environ. Res. 2012. Vol. 116. P. 85–92. 59. Sigurs N., Hattevig G., Kjellman B. Maternal avoidance of eggs, cow’s milk, and fish during lactation: effect on allergic manifestations, skin-prick tests, and specific IgE antibodies in children at age 4 years. // Pediatrics. 1992. Vol. 89, № 4 Pt 2. P. 735–739. 60. Hattevig G., Sigurs N., Kjellman B. Effects of maternal dietary avoidance during lactation on allergy in children at 10 years of age. // Acta Paediatr. 1999. Vol. 88, № 1. P. 7–12. 61. Lilja G. et al. Immune response of the atopic woman and foetus: effects of high- and lowdose food allergen intake during late pregnancy. // Clin. Allergy. 1988. Vol. 18, № 2. P. 131–142. 62. Cant A.J. et al. Effect of maternal dietary exclusion on breast fed infants with eczema: two controlled studies. // Br. Med. J. (Clin. Res. Ed). 1986. Vol. 293, № 6541. P. 231–233. 63. Pollard C, Phil M B.S. Influence of maternal diet during lactation upon allergic manifestations in infants: tolerization or sensitization. // J Allergy Clin Immunol. 1996. № 97. P. 240. 64. Kramer M.S., Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. // Cochrane database Syst. Rev. 2012. № 9. P. CD000133. 65. American Academy of Pediatrics. Committee on Nutrition. Hypoallergenic infant formulas. // Pediatrics. 2000. Vol. 106, № 2 Pt 1. P. 346–349. 66. Høst A. et al. Dietary products used in infants for treatment and prevention of food allergy. Joint Statement of the European Society for Paediatric Allergology and Clinical Immunology (ESPACI) Committee on Hypoallergenic Formulas and the European Society for Paediatric // Arch. Dis. Child. 1999. Vol. 81, № 1. P. 80–84. 67. Zeiger R.S. Food allergen avoidance in the prevention of food allergy in infants and children. // Pediatrics. 2003. Vol. 111, № 6 Pt 3. P. 1662–1671. 68. Pali-Schöll I., Renz H., Jensen-Jarolim E. Update on allergies in pregnancy, lactation, and early childhood. // J. Allergy Clin. Immunol. 2009. Vol. 123, № 5. P. 1012–1021. 69. Fälth-Magnusson K., Kjellman N.I. Development of atopic disease in babies whose 36 mothers were receiving exclusion diet during pregnancy--a randomized study. // J. Allergy Clin. Immunol. 1987. Vol. 80, № 6. P. 868–875. 70. Lovegrove J.A., Hampton S.M., Morgan J.B. The immunological and long-term atopic outcome of infants born to women following a milk-free diet during late pregnancy and lactation: a pilot study // Br. J. Nutr. 1994. Vol. 71, № 2. P. 223–238. 71. Dewey K.G. et al. Maternal versus infant factors related to breast milk intake and residual milk volume: the DARLING study. // Pediatrics. 1991. Vol. 87, № 6. P. 829–837. 72. Michaelsen K.F. et al. The Copenhagen Cohort Study on Infant Nutrition and Growth: breast-milk intake, human milk macronutrient content, and influencing factors // Am. J. Clin. Nutr. 1994. Vol. 59, № 3. P. 600–611. 73. McCrory M.A. et al. Randomized trial of the short-term effects of dieting compared with dieting plus aerobic exercise on lactation performance // Am. J. Clin. Nutr. 1999. Vol. 69, № 5. P. 959–967. 74. Dusdieker L.B., Hemingway D.L., Stumbo P.J. Is milk production impaired by dieting during lactation? // Am. J. Clin. Nutr. 1994. Vol. 59, № 4. P. 833–840. 75. Butte N.F. et al. Human milk intake and growth faltering of rural Mesoamerindian infants // Am. J. Clin. Nutr. 1992. Vol. 55, № 6. P. 1109–1116. 76. Orr-Ewing A.K., Heywood P.F., Coward W.A. Longitudinal measurements of breast milk output by a 2H2O tracer technique in rural Papua New Guinean women. // Hum. Nutr. Clin. Nutr. 1986. Vol. 40, № 6. P. 451–467. 77. de Kanashiro H.C. et al. Consumption of food and nutrients by infants in Huascar (Lima), Peru // Am. J. Clin. Nutr. 1990. Vol. 52, № 6. P. 995–1004. 78. Imong S.M. et al. Predictors of Breast Milk Intake in Rural Northern Thailand // J. Pediatr. Gastroenterol. Nutr. 1989. Vol. 8, № 3. P. 359–370. 79. Brown K.H. et al. Lactational capacity of marginally nourished mothers: relationships between maternal nutritional status and quantity and proximate composition of milk. // Pediatrics. 1986. Vol. 78, № 5. P. 909–919. 80. Milinco M. et al. Effectiveness of biological nurturing on early breastfeeding problems: a randomized controlled trial // Int. Breastfeed. J. 2020. Vol. 15, № 1. P. 21. 81. Кулагина, Н.В., Спесивцев Ю.А. Доброкачественные заболевания молочных желез и патология лактации. 2007. 82. World Health Organization. Mastitis - Causes and Management // World Heal. Organ. 2000. P. 1–44. 83. Chu J.Y. et al. [The effect of breast massage at different time in the early period after 37 cesarean section]. // Zhonghua Yu Fang Yi Xue Za Zhi. 2017. Vol. 51, № 11. P. 1038– 1040. 84. Радзинский В.Е. Медицина молочной железы и гинекологические болезни. 2017. 352 p. 85. Fact Sheet . Drugs and Lactation Database ( LactMed ® ) Web Access / Searching. 86. Harris K. et al. Safety of Cabergoline for Postpartum Lactation Inhibition or Suppression: A Systematic Review // J. Obstet. Gynaecol. Canada. 2020. Vol. 42, № 3. P. 308-315.e20. 87. McGuire T.M. Drugs affecting milk supply during lactation // Aust. Prescr. 2018. Vol. 41, № 1. P. 7–9. 88. European Medicines Agency. CMDh endorses restricted use of bromocriptine for stopping breast milk production. 2014. Vol. 44, № August. P. 1–3. 89. Swift K., Janke J. Breast Binding … Is It All That It’s Wrapped Up To Be? // J. Obstet. Gynecol. Neonatal Nurs. 2003. Vol. 32, № 3. P. 332–339. 90. NSW Government Health. Medication to dry up your milk – lactation suppression // NSW Gov. Heal. 2018. 91. SUPPRESSION OF LACTATION OR WEANING // The royal hospital for women. P. 18. 92. Hashemi Jam M.S., Roustaei Z. Lactation Suppression Treatments // Sarem J. Reprod. Med. 2016. Vol. 1, № 1. P. 29–34. 93. Fetherston C. Risk Factors for Lactation Mastitis // J. Hum. Lact. 1998. Vol. 14, № 2. P. 101–109. 94. Heesen M. et al. International consensus statement on the use of uterotonic agents during caesarean section. // Anaesthesia. 2019. Vol. 74, № 10. P. 1305–1319. 95. Gallos I.D. et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. // Cochrane database Syst. Rev. 2018. Vol. 4. P. CD011689. 96. Dahlke J.D. et al. Prevention and management of postpartum hemorrhage: a comparison of 4 national guidelines. // Am. J. Obstet. Gynecol. 2015. Vol. 213, № 1. P. 76.e1-76.e10. 97. Evensen A., Anderson J.M., Fontaine P. Postpartum Hemorrhage: Prevention and Treatment. // Am. Fam. Physician. 2017. Vol. 95, № 7. P. 442–449. 98. Knight M. et al. Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial // Lancet. 2019. Vol. 393, № 10189. P. 2395–2403. 99. Murphy D., Strachan B., Bahl R. Assisted Vaginal Birth // BJOG An Int. J. Obstet. Gynaecol. 2020. Vol. 127, № 9. 38 100. Knight M. et al. Prophylactic antibiotics for the prevention of infection following operative vaginal delivery (ANODE): study protocol for a randomised controlled trial // Trials. 2018. Vol. 19, № 1. P. 395. 101. Practice Bulletin No. 165: Prevention and Management of Obstetric Lacerations at Vaginal Delivery // Obstet. Gynecol. 2016. Vol. 128, № 1. P. e1–e15. 102. WHO Recommendations for Prevention and Treatment of Maternal Peripartum Infections. Geneva: World Health Organization; 2015. 103. van Schalkwyk J., Van Eyk N., INFECTIOUS DISEASES COMMITTEE. Antibiotic prophylaxis in obstetric procedures. // J. Obstet. Gynaecol. Can. 2010. Vol. 32, № 9. P. 878–884. 104. Stock L. et al. Factors associated with wound complications in women with obstetric anal sphincter injuries (OASIS). // Am. J. Obstet. Gynecol. 2013. Vol. 208, № 4. P. 327.e1-6. 105. Lewicky-Gaupp C. et al. Wound complications after obstetric anal sphincter injuries. // Obstet. Gynecol. 2015. Vol. 125, № 5. P. 1088–1093. 106. Duggal N. et al. Antibiotic prophylaxis for prevention of postpartum perineal wound complications: a randomized controlled trial. // Obstet. Gynecol. 2008. Vol. 111, № 6. P. 1268–1273. 107. Sénat M.-V. et al. Postpartum practice: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians (CNGOF). // Eur. J. Obstet. Gynecol. Reprod. Biol. 2016. Vol. 202. P. 1–8. 108. Paladine H.L., Blenning C.E., Strangas Y. Postpartum Care: An Approach to the Fourth Trimester. // Am. Fam. Physician. 2019. Vol. 100, № 8. P. 485–491. 109. Turawa E.B., Musekiwa A., Rohwer A.C. Interventions for treating postpartum constipation. // Cochrane database Syst. Rev. 2014. № 9. P. CD010273. 110. Milman N. Postpartum anemia I: definition, prevalence, causes, and consequences // Ann. Hematol. 2011. Vol. 90, № 11. P. 1247–1253. 111. Greer F.R., Hollis B.W., Napoli J.L. High concentrations of vitamin D2 in human milk associated with pharmacologic doses of vitamin D2 // J. Pediatr. 1984. Vol. 105, № 1. P. 61–64. 112. Specker B.L. Effect of Race and Diet on Human-Milk Vitamin D and 25-Hydroxyvitamin D // Arch. Pediatr. Adolesc. Med. 1985. Vol. 139, № 11. P. 1134. 113. Misra M. et al. Vitamin D Deficiency in Children and Its Management: Review of Current Knowledge and Recommendations // Pediatrics. 2008. Vol. 122, № 2. P. 398–417. 114. Becker D. V. et al. Iodine Supplementation for Pregnancy and Lactation—United States 39 and Canada: Recommendations of the American Thyroid Association // Thyroid. 2006. Vol. 16, № 10. P. 949–951. 115. Harding K.B. et al. Iodine supplementation for women during the preconception, pregnancy and postpartum period // Cochrane Database Syst. Rev. 2017. Vol. 2017, № 3. 116. Alexander E.K. et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum // Thyroid. 2017. Vol. 27, № 3. P. 315–389. 117. Practice Bulletin No. 181: Prevention of Rh D Alloimmunization // Obstet. Gynecol. 2017. Vol. 130, № 2. P. e57–e70. 118. ACOG Practice Bulletin No. 192 Summary: Management of Alloimmunization During Pregnancy // Obstet. Gynecol. 2018. Vol. 131, № 3. P. 611–612. 119. Савельева Г.М. et al. Резус-сенсибилизация. Гемолитическая болезнь плода. Клинические рекомендации (протокол). М., 2017. 16 с. 120. UK Blood Transfusion Services. Guidelines for the Blood Transfusion Service. 8th ed. London: TSO; 2013. 121. Guidelines for blood grouping and red cell antibody testing during pregnancy. British Committee for Standards in Haematology, Blood Transfusion Task Force. // Transfus. Med. 1996. Vol. 6, № 1. P. 71–74. 122. Shen R., Sandler S.G. Transfusion medicine illustrated. Miscounting even one lymphocyte in the Kleihauer-Betke (acid-elution) assay can result in overdosing Rh immune globulin. // Transfusion. 2015. Vol. 55, № 9. P. 2069. 123. Girard M. et al. [Trauma and pregnancy: Is the Kleihauer-Betke test really useful?] // Gynecol. Obstet. Fertil. Senol. 2017. Vol. 45, № 11. P. 584–589. 124. Spychalska J. et al. [Standardization of the quantitative flow cytometric test with anti-D antibodies for fetomaternal hemorrhage in RhD negative women]. // Ginekol. Pol. 2015. Vol. 86, № 7. P. 486–493. 125. Lebrun B., Jacquemyn Y. Usefulness of maternal fetal red blood cell count in rhesuspositive pregnant women. // Horm. Mol. Biol. Clin. Investig. 2018. Vol. 35, № 3. 126. Samson D., Mollison P.L. Effect on primary Rh immunization of delayed administration of anti-Rh. // Immunology. 1975. Vol. 28, № 2. P. 349–357. 127. Jacobs A. et al. S3-Guidelines for the Treatment of Inflammatory Breast Disease during the Lactation Period // Geburtshilfe Frauenheilkd. 2013. Vol. 73, № 12. P. 1202–1208. 128. Oladapo O.T., Fawole B. Treatments for suppression of lactation // Cochrane Database Syst. Rev. 2012. 40 129. Marcellin L., Chantry A.A. Allaitement maternel (partie II) : méthodes d’inhibition de la lactation – recommandations pour la pratique clinique // J. Gynécologie Obs. Biol. la Reprod. 2015. Vol. 44, № 10. P. 1080–1083. 130. Ring D., Retzke U., Vollmar F. [Postpartum curettage--is it always indicated?]. // Zentralbl. Gynakol. 1988. Vol. 110, № 15. P. 949–952. 131. Hertzberg B.S., Bowie J.D. Ultrasound of the postpartum uterus. Prediction of retained placental tissue. // J. Ultrasound Med. 1991. Vol. 10, № 8. P. 451–456. 132. van den Bosch T. et al. Occurrence and Outcome of Residual Trophoblastic Tissue // J. Ultrasound Med. 2008. Vol. 27, № 3. P. 357–361. 133. Barel O. et al. Intrauterine adhesions after hysteroscopic treatment for retained products of conception: what are the risk factors? // Fertil. Steril. 2015. Vol. 103, № 3. P. 775–779. 134. Smorgick N. et al. Postpartum Retained Products of Conception: A Novel Approach to Follow-Up and Early Diagnosis // Ultraschall der Medizin - Eur. J. Ultrasound. 2018. Vol. 39, № 06. P. 643–649. 135. Smorgick N. et al. Hysteroscopic management of retained products of conception: metaanalysis and literature review // Eur. J. Obstet. Gynecol. Reprod. Biol. 2014. Vol. 173. P. 19–22. 136. March C.M., Israel R., March A.D. Hysteroscopic management of intrauterine adhesions // Am. J. Obstet. Gynecol. 1978. Vol. 130, № 6. P. 653–657. 137. Hooker A.B. et al. Immediate and long-term complications of delayed surgical management in the postpartum period: a retrospective analysis // J. Matern. Neonatal Med. 2015. Vol. 28, № 16. P. 1884–1889. 138. Jauniaux E., Alfirevic Z., Bhide A.G., Belfort M.A., Burton G.J., Collins S.L. et al. Placenta praevia and placenta accreta: diagnosis and management: Green-top Guideline No. 27a. // BJOG An Int J Obs. Gynaecol. 2019. Vol. 126, № 1. P. e1–48. 139. Hobson S.R., Kingdom J.C., Murji A., Windrim R.C., Carvalho J.C.A., Singh S.S. et al. Screening, diagnosis, and management of placenta accreta spectrum disorders. // J Obs. Gynaecol Canada. 2019. Vol. 41, № 7. P. 1035–1049. 140. Collins S.L., Alemdar B., Beekhuizen H.J., Bertholdt C., Braun T., Calda P. et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the international society for abnormally invasive placenta. // Am J Obs. Gynecol. 2019. Vol. 220, № 6. P. 511–526. 141. Cahill A.G., Beigi R., Heine R.P., Silver R.M. W.J.R. Placenta accreta spectrum. // Am J Obs. Gynecol. 2018. Vol. 219, № 6. P. B2–16. 41 142. Legendre G., Zoulovits F.J., Kinn J., Senthiles L. F.H. Conservative management of placenta accreta: hysteroscopic resection of retained tissues. // J Minim Invasive Gynecol. 2014. Vol. 21, № 5. P. 910–913. 143. Ye M., Yin Z., Xue M. D.X. High-intensity focused ultrasound combined with hysteroscopic resection for the treatment of placenta accreta. // BJOG An Int J Obs. Gynaecol. 2017. Vol. 124. P. 71–77. 144. Alsulihem A., Corcos J. The use of vaginal lasers in the treatment of urinary incontinence and overactive bladder, systematic review. // Int. Urogynecol. J. 2021. Vol. 32, № 3. P. 553–572. 145. Магнитотерапия в лечебно-реабилитационных и профилактических программах: клинические рекомендации. 2015. P. 47. 146. Лазерная терапия в лечебно-реабилитационных и профилактических программах: клинические рекомендации. 2015. P. 68. 147. Г.Н. Пономаренко, Ковлен Д.В. ДПП ПК Физическая и реабилитационная медицина. Нормативное правовое регулирование.PDF. 2018. P. 28. 148. Thombs B.D. et al. Overestimation of Postpartum Depression Prevalence Based on a 5- item Version of the EPDS: Systematic Review and Individual Participant Data Metaanalysis // Can. J. Psychiatry. 2020. Vol. 65, № 12. P. 835–844. 149. Levis B. et al. Accuracy of the Edinburgh Postnatal Depression Scale (EPDS) for screening to detect major depression among pregnant and postpartum women: systematic review and meta-analysis of individual participant data // BMJ. 2020. P. m4022. 150. National Collaborating Centre for Mental Health. Antenatal and Postnatal Mental Health: The NICE Guideline On Clinical Management and Service Guidance // Antenatal and postnatal mental health: the NICE guideline on clinical management and service guidance. 2007. 369 p. 151. Khanlari S. et al. Re-examination of perinatal mental health policy frameworks for women signalling distress on the Edinburgh Postnatal Depression Scale (EPDS) completed during their antenatal booking-in consultation: a call for population health intervention // BMC Pregnancy Childbirth. 2019. Vol. 19, № 1. P. 221. 152. Albanese A.M. et al. In Their Own Words: A Qualitative Investigation of the Factors Influencing Maternal Postpartum Functioning in the United States // Int. J. Environ. Res. Public Health. 2020. Vol. 17, № 17. P. 6021. 153. Senger C.A. Evidence Synthesis Number 172 Interventions to Prevent Perinatal Depression : A Systematic Evidence Review for the U . S . Preventive Services Task 42 Force. 2015. № 172. 154. McCurdy A.P. et al. Effects of Exercise on Mild-to-Moderate Depressive Symptoms in the Postpartum Period // Obstet. Gynecol. 2017. Vol. 129, № 6. P. 1087–1097. 155. Emamian F. et al. Link between insomnia and perinatal depressive symptoms: A meta‐ analysis // J. Sleep Res. 2019. Vol. 28, № 6. 156. Stephens S. et al. Effectiveness of Psychological Interventions for Postnatal Depression in Primary Care: A Meta-Analysis // Ann. Fam. Med. 2016. Vol. 14, № 5. P. 463–472. 157. Siu A.L. et al. Screening for Depression in Adults // JAMA. 2016. Vol. 315, № 4. P. 380. 158. Earls M.F. Incorporating Recognition and Management of Perinatal and Postpartum Depression Into Pediatric Practice // Pediatrics. 2010. Vol. 126, № 5. P. 1032–1039. 159. Rezaie-Keikhaie K. et al. Systematic Review and Meta-Analysis of the Prevalence of the Maternity Blues in the Postpartum Period. // J. Obstet. Gynecol. neonatal Nurs. JOGNN. 2020. Vol. 49, № 2. P. 127–136. 160. Banasiewicz J. et al. Perinatal Predictors of Postpartum Depression: Results of a Retrospective Comparative Study // J. Clin. Med. 2020. Vol. 9, № 9. P. 2952. 161. Bohren M.A. et al. The Mistreatment of Women during Childbirth in Health Facilities Globally: A Mixed-Methods Systematic Review // PLOS Med. / ed. Jewkes R. 2015. Vol. 12, № 6. P. e1001847. 162. Balaram K., Marwaha R. Postpartum Blues // StatPearls. 2021. 163. Программа оптимизации вскармливания детей первого года жизни в Российской Федерации. Методические рекомендации ФГАУ «НМИЦ здоровья детей» Минздрава России. 2019. 112 p. 164. World Health Organization. Infant and young child feeding: model chapter for textbooks for medical students and allied health professionals. 2009. 112 p. 165. World Health Organization. Infant and young child feeding counselling: an integrated course. 2006. 254 p. 166. Spencer J. P. Management of Mastitis in Breastfeeding Women. // Am. Fam. Physician. 2008. № 78(6). P. 727–731. 167. Jahanfar S., Ng C.J., Teng C.L. Antibiotics for mastitis in breastfeeding women // Cochrane Database Syst. Rev. 2013. 168. World Health Organization. The base of newborn care and breastfeeding. Part I. 1997. 178 p. 169. Vinter, T.; Hel’sing E.. B. How to ensure success: a practical guide for health professionals. Copenhagen: WHO. 1997. 100 p. 43 170. Vorontsov I.M. F.E.M. Breast feeding children. Its value and support. 1998. 272 p. 171. World Health Organization. Breastfeeding counseling: a training course: a guide for teachers. 1993. 422 p. 172. World Health Organization. Infant feeding: A guide for mothers. 1997. 53 p. 173. World Health Organization. Breastfeeding promotion and support in a baby-friendly hospital: a 20-hour course for maternity staff. Section 3. p. 2009. 274 p. 174. Lumbiganon P. et al. Antenatal breastfeeding education for increasing breastfeeding duration. // Cochrane database Syst. Rev. 2011. № 11. P. CD006425. 175. Zakharova I.N. et al. Caesarean section and lactation problems in women // Med. Counc. 2018. № 17. P. 22–29. 176. Ryumina I.I., Levadnaya A. V., Zubkov V. V. Lactostasis and prevention of lactation mastitis: role of neonatologist and pediatrician // Meditsinskiy Sov. = Med. Counc. 2020. № 1. P. 170–175. 177. McFadden A. et al. Support for healthy breastfeeding mothers with healthy term babies. // Cochrane database Syst. Rev. 2017. Vol. 2. P. CD001141. 178. Гуменюк О.И. Ч.Ю.В. Заболевания молочных желез у девочек подростков (обзор) // Саратовский научно-медицинский журнал. 2011. № 7 (2). P. 465 – 470. 179. ВОЗ Е. региональное бюро. Грудное вскармливание: как поддержать успех Практическое руководство для медицинских работников. 1997. 90 p. 180. Walker M. Breastfeeding management for the clinician: using the evidence. 2006. 630 p. 181. Dewey K.G. et al. Risk Factors for Suboptimal Infant Breastfeeding Behavior, Delayed Onset of Lactation, and Excess Neonatal Weight Loss // Pediatrics. 2003. Vol. 112, № 3. P. 607–619. 182. N. M. Breastfeeding answers Made simple A guide for helping mother. 2010. 183. Ramsay D.T. et al. Anatomy of the lactating human breast redefined with ultrasound imaging // J. Anat. 2005. Vol. 206, № 6. P. 525–534. 184. Skandalakis J.E., Skandalakis P.N., Weidman T.A. S.L.J. Skandalakis’ Surgical Anatomy. 2004. 185. Vazirinejad R. et al. The effect of maternal breast variations on neonatal weight gain in the first seven days of life // Int. Breastfeed. J. 2009. Vol. 4, № 1. P. 13. 186. Zucca-Matthes G., Urban C., Vallejo A. Anatomy of the nipple and breast ducts. // Gland Surg. 2016. Vol. 5, № 1. P. 32–36. 187. Alexander J.M., Grant A.M., Campbell M.J. Randomised controlled trial of breast shells and Hoffman’s exercises for inverted and non-protractile nipples. // BMJ. 1992. Vol. 304, 44 № 6833. P. 1030–1032. 188. Баев О.Р. et al. Клинический протокол “Антибиотикопрофилактика при проведении абдоминального родоразрешения (кесарево сечение)”. // Акушерство и гинекология. 2011. № 4. P. 15–16. 189. Тютюнник В.Л. et al. Федеральные клинические рекомендации. Антибиотикопрофилактика при абдоминальном родоразрешении. 2013. - 13 с. 190. Fraissinet F. et al. Pharmacokinetics of Teicoplanin in a Breastfeeding Mother // Breastfeed. Med. 2017. Vol. 12, № 4. P. 244–246. 191. Kaplan Y.C. et al. Teicoplanin Use During Breastfeeding // Breastfeed. Med. 2017. Vol. 12, № 2. P. 124–124. 192. Cherif F., El Aidli S. K.S. et al. Drug induced urticaria via breastfeeding // FundamClinPharmacol. 2009. № 23 (1). P. 37. 193. Celiloglu M. et al. Gentamicin excretion and uptake from breast milk by nursing infants. // Obstet. Gynecol. 1994. Vol. 84, № 2. P. 263–265. 194. Boda A. [Gentamycin concentration in the milk of a mother after treatment by implantation of a Septopal chain]. // Orv. Hetil. 1990. Vol. 131, № 41. P. 2263–2265. 195. Festini F., Ciuti R. R.T. et al. Safety of breast-feeding during an IV tobramycin course for infants of CF women // PediatrPulmonolSuppl. 2004. № 27. P. 288–289. 196. Manninen A.K., Juhakoski A. Nifedipine concentrations in maternal and umbilical serum, amniotic fluid, breast milk and urine of mothers and offspring. // Int. J. Clin. Pharmacol. Res. 1991. Vol. 11, № 5. P. 231–236. 197. Berens P. et al. ABM Clinical Protocol #26: Persistent Pain with Breastfeeding // Breastfeed. Med. 2016. Vol. 11, № 2. P. 46–53. 198. Duke M.E. et al. Maternal Metyrapone Use During Breastfeeding: Safe for the Breastfed Infant. // J. Endocr. Soc. 2019. Vol. 3, № 5. P. 973–978. 199. Smuin D.M. et al. Rare Adverse Events Associated with Corticosteroid Injections: A Case Series and Literature Review. // Curr. Sports Med. Rep. Vol. 15, № 3. P. 171–176. 200. Ryu R.J. et al. Prednisone Pharmacokinetics During Pregnancy and Lactation. // J. Clin. Pharmacol. 2018. Vol. 58, № 9. P. 1223–1232. 201. Davanzo R. et al. Breastfeeding and migraine drugs // Eur. J. Clin. Pharmacol. 2014. Vol. 70, № 11. P. 1313–1324. 202. Anderson P.O., Manoguerra A.S., Valdés V. A Review of Adverse Reactions in Infants From Medications in Breastmilk // Clin. Pediatr. (Phila). 2016. Vol. 55, № 3. P. 236–244. 203. Götestam Skorpen C. et al. The EULAR points to consider for use of antirheumatic drugs 45 before pregnancy, and during pregnancy and lactation. // Ann. Rheum. Dis. 2016. Vol. 75, № 5. P. 795–810. 204. Flint J. et al. BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids. // Rheumatology (Oxford). 2016. Vol. 55, № 9. P. 1693–1697. 205. Constantinescu S. et al. Breast-feeding after transplantation // Best Pract. Res. Clin. Obstet. Gynaecol. 2014. Vol. 28, № 8. P. 1163–1173. 206. Karimova K.G.N. et al. Current approaches to the echographic monitoring of uterine involution in the postpartum period: Impact on management tactics // Akush. Ginekol. (Sofiia). 2016. Vol. 3_2016. P. 43–48. 207. Wachsberg R.H. et al. Real-time ultrasonographic analysis of the normal postpartum uterus: technique, variability, and measurements. // J. Ultrasound Med. 1994. Vol. 13, № 3. P. 215–221. 208. Wachsberg R.H., Kurtz A.B. Gas within the endometrial cavity at postpartum US: a normal finding after spontaneous vaginal delivery. // Radiology. 1992. Vol. 183, № 2. P. 431–433. 209. Sentilhes L. et al. FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management, // Int. J. Gynecol. Obstet. 2018. Vol. 140, № 3. P. 291–298. 210. Mulic-Lutvica A., Axelsson O. Postpartum ultrasound in women with postpartum endometritis, after cesarean section and after manual evacuation of the placenta // Acta Obstet. Gynecol. Scand. 2007. Vol. 86, № 2. P. 210–217. 211. Mulic-Lutvica A. Postpartum Ultrasound // Donald Sch. J. Ultrasound Obstet. Gynecol. 2012. Vol. 6, № 1. P. 76–92. 212. Scott J., Huskisson E.C. Graphic representation of pain. // Pain. 1976. Vol. 2, № 2. P. 175–184.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
СПИСОК ЛИТЕРАТУРЫ
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*